CAH

Introduction to Congenital Adrenal Hyperplasia (CAH)

Adrenal Gland Functions

• Adrenal Gland Composition

  • Zona Glomerulosa:

  • Function: Produces mineralocorticoids, mainly aldosterone.

  • Role: Regulates salt balance in the body.

  • Zona Fasciculata:

  • Function: Produces glucocorticoids, primarily cortisol.

  • Role: Body's stress response, important for energy utilization.

  • Zona Reticularis:

  • Function: Produces sex androgens, including testosterone.

Key Enzyme: 21-Hydroxylase

• Importance:

  • Enzyme involved in both mineralocorticoid and glucocorticoid pathways.

  • Impact: Affects salt balance and cortisol production.

Understanding CAH

• Definition of CAH:

  • Condition marked by enlarged adrenal glands based on autopsy findings.

• Genetic Basis:

  • CAH is an autosomal recessive condition.

  • Requires inheritance of gene variants from both parents.

• Mechanism of Pathology:

  • Mutations occur in genes coding for enzymes in steroid synthesis pathways, leading to abnormal steroid levels.

Steroid Pathway Block and Its Consequences

• Pathway Blockage:

  • In conditions such as 21-hydroxylase CAH, there is a blockage of hormone production, leading to:

  • Deficiency in aldosterone and cortisol production.

  • Increased production of androgens due to hormonal shifts.

Feedback Mechanism

• Feedback Loop Involved:

  • ACTH produced by the pituitary gland stimulates adrenal hormone production.

  • Low cortisol levels lead to increased ACTH production, causing further accumulation of androgens (e.g., testosterone).

• Clinical Implications:

  • Symptoms: Hyperpigmentation due to high ACTH levels, fatigue from low cortisol, dehydration from low aldosterone.

Clinical Features of CAH

• General Symptoms:

  • Fatigue, hypoglycemia, weakness, poor weight gain, poor appetite due to inadequate cortisol.

  • Low sodium, high potassium levels leading to dehydration.

  • Excess androgens causing virilization effects in genetically female patients.

• Presentation Variability:

  • Manifestation can vary widely from mild to severe genital anomalies, often categorized using the Prader scale for genital development.

Classification of 21-Hydroxylase Deficiency

• Two Main Types:

  • Salt-Wasting CAH:

  • Characteristics: Significant deficiency in both mineralocorticoids and glucocorticoids, emergency presentation in infancy, often with ambiguous genitalia.

  • Causes: No enzymatic activity of 21-hydroxylase.

• Simple Virilizing CAH:

  • Characteristics: Some residual enzyme activity ensuring minimal mineralocorticoid production, associated with low glucocorticoids, manifests slightly later.

  • Symptoms: Early puberty characteristics in childhood, higher than average stature.

Diagnosis of CAH

• Key Diagnostic Markers:

  • Elevated ACTH levels.

  • Significant increase in 17-hydroxyprogesterone (17 OHP).

  • Low cortisol levels, best assessed via stimulation tests (e.g., Synacthen test).

  • Urinary steroid metabolites profiling is crucial in diagnosing adrenal pathway disorders.

Urine Steroid Profiling

• Overview:

  • Assessment of steroid metabolites to diagnose adrenal disorders.

  • Mass spectrometry is preferred for its accuracy in quantifying various metabolites.

Detailed Case Studies in CAH

Case 1: 21-Hydroxylase Deficiency

• Presentation: Newborn with ambiguous genitalia, enlarged clitoris, and hyperpigmentation.

• Genetic Karyotype: 46 XX, indicating female.

• Key Findings:

  • Elevated ACTH and 17 OHP levels, low cortisol.

  • Urine steroid profile confirms deficiency.

• Treatment: Hydrocortisone and fludrocortisone with regular monitoring.

Case 2: 11-Hydroxylase Deficiency

• Presentation: Ambiguous genitalia, normal internal reproductive organs evident from ultrasound.

• Key Findings:

  • Elevated 17 OHP, normal sodium and potassium but elevated renin and cortisol levels were low.

  • Urine steroid profile indicated elevated aldosterone metabolites leading to hypertension.

• Therapy: Replace deficient cortisol without excessive fluid.

Case 3: 17-Alpha Hydroxylase Deficiency

• Presentation: Under-virilized male, small penis; need for evaluation into puberty.

• Karyotype: 46 XY.

• Key Findings:

  • Extremely low testosterone, with normal gonadal response.

  • Urine steroid profile indicated low androgens and high aldosterone.

  • Treatment involved monitoring and treatment with hydrocortisone, addressing hypertension accordingly.

Case 4: 3-Beta Hydroxysteroid Dehydrogenase Deficiency

• Presentation: Ambiguous genitalia, bilateral palpable testes, salt-wasting state.

• Key Findings:

  • Diagnosed through elevated precursor levels (DHEA).

• Treatment involved management similar to classic CAH, with monitoring for salt-wasting.

Rare Variants of CAH

• P450 Oxidoreductase Deficiency:

  • Affects several adrenal enzymes, leading to varying phenotypes.

  • Biochemical complexity due to shared pathways affecting multiple hormones.

• Lipoid CAH:

  • Result from STAR gene defect leading to impaired cholesterol transport into steroidogenesis.

  • Present with severely under-virilized males and ambiguous females due to high levels of salts affecting hormone pathways.

Summary of Key Findings

• Many forms of CAH exist, with 21-hydroxylase deficiency being the most prevalent.

• Clinical manifestations are directly tied to specific enzymatic deficiencies in the steroid pathways, along with varying patterns of hypertension, virilization, and salt-wasting symptoms.

• Monitoring and treatment are vital for managing conditions, particularly through urine steroid profiles, hormonal replacement therapies, and regular follow-ups for optimal outcomes in affected individuals.

Questions

• Question from audience regarding testes' androgen production compensating in certain enzyme deficiencies.

• Answer highlights limitations of compensatory mechanisms due to the quiescent state of the hypothalamic-pituitary axis affecting androgen production.